Dirk Grosse Meininghaus1, Kai Blembel2, Claudia Waniek3, Juergen Kruells-Muench2, Helmut Ernst4, Tobias Kleemann4, J Christoph Geller5. 1. Department of Cardiology, Carl-Thiem-Hospital Cottbus, Germany. Electronic address: dirk_gm@t-online.de. 2. Department of Cardiology, Carl-Thiem-Hospital Cottbus, Germany. 3. Department of Cardiology, Carl-Thiem-Hospital Cottbus, Germany; Thiem Research, Carl-Thiem-Hospital Cottbus, Germany. 4. Department of Gastroenterology, Carl-Thiem-Hospital Cottbus, Germany. 5. Division of Cardiology, Arrhythmia Section, Zentralklinik Bad Berka, Germany; Otto-von-Guericke University School of Medicine, Magdeburg, Germany.
Abstract
BACKGROUND: Endoscopically detected esophageal lesions (EDELs) are common following pulmonary vein isolation (PVI) and may progress to atrioesophageal fistula (AEF). OBJECTIVE: The purpose of this study was to study (1) the benefit of luminal esophageal temperature (LET) monitoring and (2) the impact of esophagogastroduodenoscopy (EGD) in detecting EDEL and defining pre-existing lesions. The primary endpoint was the number of ablation-induced lesions. METHODS: Patients with atrial fibrillation were randomized to PVI with LET monitoring (LET[+]) or without LET monitoring (LET[-]). All patients underwent EGD before and after PVI. Ablation power at the left atrial (LA) posterior wall was limited to 25 W in all patients and was titrated to a minimum of 10 W guided by esophageal temperature in the LET[+] group. RESULTS: Eighty-six patients (age 67 ± 10 years; 57% male) were included (44 LET[+], 42 LET[-]). PVI was achieved in all, and additional linear LA lesions were done in 50%. Eight patients developed EDEL (6 LET[+], 2 LET[-]; P = NS). Whereas LET <41°C did not differentiate with regard to EDEL formation, temperature overshooting ≥42°C was associated with a higher risk for new EDEL. Two-thirds of patients showed incidental findings (esophagitis, gastric ulcer) on preprocedural EGD; 8 esophageal lesions were pre-existing. Four patients in the LET[+] group developed epistaxis following insertion of the probe. CONCLUSION: Monitoring of LET does not prevent ablation-induced esophageal lesions. Patients without temperature surveillance were not at higher risk, but temperatures ≥42°C were associated with increased likelihood of mucosal lesions.
BACKGROUND: Endoscopically detected esophageal lesions (EDELs) are common following pulmonary vein isolation (PVI) and may progress to atrioesophageal fistula (AEF). OBJECTIVE: The purpose of this study was to study (1) the benefit of luminal esophageal temperature (LET) monitoring and (2) the impact of esophagogastroduodenoscopy (EGD) in detecting EDEL and defining pre-existing lesions. The primary endpoint was the number of ablation-induced lesions. METHODS: Patients with atrial fibrillation were randomized to PVI with LET monitoring (LET[+]) or without LET monitoring (LET[-]). All patients underwent EGD before and after PVI. Ablation power at the left atrial (LA) posterior wall was limited to 25 W in all patients and was titrated to a minimum of 10 W guided by esophageal temperature in the LET[+] group. RESULTS: Eighty-six patients (age 67 ± 10 years; 57% male) were included (44 LET[+], 42 LET[-]). PVI was achieved in all, and additional linear LA lesions were done in 50%. Eight patients developed EDEL (6 LET[+], 2 LET[-]; P = NS). Whereas LET <41°C did not differentiate with regard to EDEL formation, temperature overshooting ≥42°C was associated with a higher risk for new EDEL. Two-thirds of patients showed incidental findings (esophagitis, gastric ulcer) on preprocedural EGD; 8 esophageal lesions were pre-existing. Four patients in the LET[+] group developed epistaxis following insertion of the probe. CONCLUSION: Monitoring of LET does not prevent ablation-induced esophageal lesions. Patients without temperature surveillance were not at higher risk, but temperatures ≥42°C were associated with increased likelihood of mucosal lesions.
Authors: Leon Iden; Sonia Busch; Daniel Steven; Roland R Tilz; Dong-In Shin; K R Julian Chun; Heidi Estner; Felix Bourier; David Duncker; Philipp Sommer; Andreas Metzner; Tilman Maurer; Nils-Christian Ewertsen; Henning Jansen; Andreas Rillig; Victoria Johnson; Till Althoff Journal: Herzschrittmacherther Elektrophysiol Date: 2021-07-26
Authors: Cheryl Teres; David Soto-Iglesias; Diego Penela; Giulio Falasconi; Daniel Viveros; Julia Meca-Santamaria; Aldo Bellido; Jose Alderete; Alfredo Chauca; Augusto Ordoñez; Julio Martí-Almor; Claudia Scherer; Alejandro Panaro; Julio Carballo; Óscar Cámara; Jose-Tomás Ortiz-Pérez; Antonio Berruezo Journal: J Interv Card Electrophysiol Date: 2022-07-21 Impact factor: 1.759
Authors: Cheryl Teres; David Soto-Iglesias; Diego Penela; Beatriz Jáuregui; Augusto Ordoñez; Alfredo Chauca; Jose Miguel Carreño; Claudia Scherer; Marina Huguet; Carlos Ramírez; José Torres Mandujano; Giuliana Maldonado; Alejandro Panaro; Julio Carballo; Óscar Cámara; Jose-Tomás Ortiz-Pérez; Antonio Berruezo Journal: Heart Rhythm O2 Date: 2022-02-13